摘要
目的探讨Mammotome旋切术在乳房肿块活检中的应用价值及对检测出的不典型增生病例的外科治疗方法.方法2003年3月～2004年1月对我院32例39处乳腺病灶超声引导下Mammotome微创旋切术及相应外科手术治疗.结果32例39处乳腺病灶中,乳腺纤维腺病24例(31处病灶),浆细胞性乳腺炎1例,非典型增生4例,乳腺癌3例.4例非典型增生中2例接受再手术,结果证实为非典型增生;1例轻度非典型增生和1例介于中度与重度非典型增生之间,口服他莫昔芬.结论对Mammotome旋切术检出的重度非典型增生,必须接受再次手术;对术前可触及肿块的中度以下的非典型增生,建议手术切除;对术前不能触及肿块的中度以下的非典型增生(不合并家族史),在肿块已全切情况下,可不手术,予他莫昔芬口服并随访.
Objective To investigate the application value of stereotactic vacuum-assisted core needle breast biopsy （Mammotome biopsy） for breast masses and the surgical treatment for atypical ductal hyperplasia （ADH） detected by the Mammotome biopsy. Methods Ultrasound guided Mammotome biopsies and corresponding surgical management were carried out in 32 patients （39 lesions） in this hospital between March 2003 and January 2004. Results Of the 32 patients （39 lesions） , fibroadenosis was diagnosed in 24 patients （31 lesions） , plasma cell mastitis in 1 patient, atypical ductal hyperplasia in 4 patients, and breast cancer, 3 patients. Of the 4 patients with atypical hyperplasia, a re-operation was conducted and a confirmative diagnosis of atypical hyperplasia was made in 2 patients, while the oral administration of Tamoxifen was given in 1 patient with mild atypical hyperplasia and in 1 patient with moderate to severe hyperplasia. Conclusions For patients with severe ADH detected by the Mammotome biopsy, a re-operation is required. For patients with mild to moderate ADH ： if the breast mass is palpable preoperatively, a surgical excision is recommended; if the patient has non-palpable masses with negative family history, in condition that the lesion has been entirely removed, the surgery is not necessary and the oral administration of Tamoxifen with regular follow-up is indicated.
出处
《中国微创外科杂志》
CSCD
2005年第9期762-763,共2页
Chinese Journal of Minimally Invasive Surgery
